IBD Treatments Don’t Seem to Raise Extracolonic Cancer Risk
Anti-TNFs in Early Puberty May Improve Growth in Pediatric IBD
TNF Blocking Drugs Persist in Infants after Exposure In-Utero

• By Lisa Rapaport
• By Reuters Staff
• By Reuters Staff
• By Anne Harding
• By Lara C. Pullen, PhD
• By Will Boggs, MD
• By Michael Shields & Ben Hirschler
• By Megan Brooks
• By Reuters Staff
• By Reuters Staff
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
The Foundation is the largest private funding source for rheumatology research and training in the U.S.